Marc H. Burel
Directeur/Membre du Conseil chez Nofusco Corp.
Profil
Marc H.
Burel is currently a Director at Nofusco Corp.
He was previously the President, Chief Operating Officer & Director at Orthobond Corp.
and the Vice President-Sales & Marketing at Osteotech, Inc.
Postes actifs de Marc H. Burel
| Sociétés | Poste | Début |
|---|---|---|
Nofusco Corp.
 Nofusco Corp. Medical SpecialtiesHealth Technology Nofusco Corp. is a company that manufactures and wholesales medical devices. The company is based in Bradenton, FL. The company was founded in 2021 by Dale Whipple, Randal R. Betz. Randal R. Betz has been the CEO since 2021. | Directeur/Membre du Conseil | - |
Anciens postes connus de Marc H. Burel
| Sociétés | Poste | Fin |
|---|---|---|
Orthobond Corp.
 Orthobond Corp. Chemicals: Major DiversifiedProcess Industries Orthobond Corp. develops chemicals to help facilitate better material surface bonding. It offers a technology based on self-assembled monolayers of phosphonate (SAMP) and osteoconductive self-assembled monolayer of phosphonate surface modification that elicits a biological response on inorganic implants without the use of a biologic. The company was founded by Gregory E. Lutz and Jeffery Schwartz in 2004 and is headquartered in North Brunswick, NJ. | President | - |
Osteotech, Inc.
 Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | Sales & Marketing | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Osteotech, Inc.
Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | Health Technology |
Orthobond Corp.
Orthobond Corp. Chemicals: Major DiversifiedProcess Industries Orthobond Corp. develops chemicals to help facilitate better material surface bonding. It offers a technology based on self-assembled monolayers of phosphonate (SAMP) and osteoconductive self-assembled monolayer of phosphonate surface modification that elicits a biological response on inorganic implants without the use of a biologic. The company was founded by Gregory E. Lutz and Jeffery Schwartz in 2004 and is headquartered in North Brunswick, NJ. | Process Industries |
Nofusco Corp.
Nofusco Corp. Medical SpecialtiesHealth Technology Nofusco Corp. is a company that manufactures and wholesales medical devices. The company is based in Bradenton, FL. The company was founded in 2021 by Dale Whipple, Randal R. Betz. Randal R. Betz has been the CEO since 2021. | Health Technology |
